PharmaCyte Biotech (PMCB) P/E (2023 - 2026)
PharmaCyte Biotech (PMCB) P/E from May 1, 2023 to Jun 12, 2026. The TTM PharmaCyte Biotech (PMCB) P/E is -1.45. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of PharmaCyte Biotech (PMCB)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.45 | +107.89% |
| 2025 | -0.70 | -230.18% |
| 2024 | 0.54 | -101.23% |
| 2023 | -43.80 | N/A |
Comparison PharmaCyte Biotech (PMCB) P/E with competitors
PharmaCyte Biotech (PMCB) P/E is -1.45.